Please provide your email address to receive an email when new articles are posted on . The FDA cleared a wearable cardiopulmonary management system. The system is designed for the remote monitoring ...
Alterations in the hematologic system, immobility, and venous stasis place the critically ill obese patient at increased risk of thrombus formation. Because increased adipose tissue may mask swelling ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Abiomed announced its compact cardiopulmonary bypass ...
In this podcast, Zachary George, Director of Hospital Certifications, The Joint Commission, and Andrea Leigh Yates, Associate Field Director for Disease Specific Care, The Joint Commission, will ...
A new wearable device captures cardiopulmonary measurements for chronic disease management—such as heart failure—in home settings and engages patient care teams only when there are indications of a ...
WILMINGTON, Mass., March 5, 2024 /PRNewswire/ -- Analog Devices, Inc. (ADI) (Nasdaq: ADI) today announced U.S. Food and Drug Administration (FDA) 510(k) clearance and the commercial launch of the ...
SUNNYVALE, Calif.--(BUSINESS WIRE)--EBR Systems, Inc., developer of the world’s only wireless cardiac pacing system for heart failure, today announced that the U.S. Food and Drug Administration (FDA) ...
Senior male patient with ECG sensor on his chest in clinic. Elderly male with face mask getting his cardiac stress test in cardiology clinic. COVID-19 induces a range of negative cardiac effects, such ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results